Ceftazidime-Avibactam
Looking at 2 Antimicrobials for Drug-Resistant Pseudomonas aeruginosa
The purpose of this review is to discuss the in vitro activity and real-world evidence of ceftolozane-tazobactam ...
FEBRUARY 26, 2025
Early Avycaz Therapy Increases Success Rates for MDR P. aeruginosa Pneumonia
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa is a prevalent and ...
AUGUST 28, 2023
Right Drug for the HABP and VABP Patient
Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia are among the most common and ...
AUGUST 23, 2023
Load more